Citations

Clear

6273 citation(s) found for "To, Andrew".

Alliance A091102: Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma.
Dickson, Mark A. , Mahoney, Michelle R., Tap, William D. , Keohan, Mary Louise , Tine, Brian Andrew Van, Agulnik, Mark , Horvath, Laura E., D'Angelo, Sandra P , Schwartz, Gary K.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 10527-10527

10.1200/jco.2014.32.15_suppl.10527 Get It

A randomized phase 3 trial of thalidomide and prednisone (TP) as maintenance therapy following autologous stem cell transplantation (ASCT) in patients with multiple myeloma (MM): An updated analysis of the NCIC Clinical Trials Group MY10 trial.
Trudel, Suzanne , White, Darrell , Sabry, Waleed , Belch, Andrew R. , Reiman, Tony , Shustik, Chaim, Kovacs, Michael J. , Sussman, Jonathan , Reece, Donna , Lacy, Martha Q. , Meyer, Ralph M., Shepherd, Lois E. , Whelan, Kate, Zhu, Liting , Chapman, Judy‐Anne W., Stewart, A. Keith, Hay, Annette E. , Bahlis, Nizar Jacques , Roy, Jean

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 8591-8591

10.1200/jco.2014.32.15_suppl.8591 Get It

Differences in disease characteristics, treatment patterns, and outcomes between men (M) and women (W) with follicular lymphoma (FL): Prospective evaluation of 2,650 U.S. patients (pts).
Nabhan, Chadi , Byrtek, Michelle, Dawson, Keith, Friedberg, Jonathan W. , Flowers, Christopher R. , Zhou, Xiaolei , Ziemiecki, Ryan , Zelenetz, Andrew D. , Cerhan, James R.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 8550-8550

10.1200/jco.2014.32.15_suppl.8550 Get It

ARIEL 2/3: An integrated clinical trial program to assess activity of rucaparib in ovarian cancer and to identify tumor molecular characteristics predictive of response.
McNeish, Iain A. , Allen, Andrew R., Raponi, Mitch , Giordano, Heidi, Maloney, Lara , Isaacson, Jeff, McNeish, Iain A , Swisher, Elizabeth M. , Coleman, Robert L. , Brenton, James D. , Kaufmann, Scott H. , Isaacson, Jeffrey D., Ledermann, Jonathan A.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: TPS5619-TPS5619

10.1200/jco.2014.32.15_suppl.tps5619 Get It

Results of a multicenter phase I/II trial of abiraterone acetate plus BEZ235 in metastatic, castration-resistant prostate cancer (mCRPC).
Siegel, Adam, Lin, Amy , Friedlander, Terence W. , Hsieh, Andrew C. , Hang, Evelyn, Weinberg, Vivian, Ryan, Charles J. , Bryce, Alan H.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: e16042-e16042

10.1200/jco.2014.32.15_suppl.e16042 Get It

A phase 2, open-label study of rucaparib in patients with pancreatic cancer and a known deleterious BRCA mutation.
Hendifar, Andrew , Shroff, Rachna T. , Leichman, Lawrence P., Epelbaum, Ron, Geva, Ravit , Kim, George P., Wolff, Robert A. , Allen, Andrew R., Giordano, Heidi, Raponi, Mitch , Isaacson, Jeffrey D., Rolfe, Lindsey, Vonderheide, Robert H. , Domchek, Susan M. , McWilliams, Robert R. , Alberts, Steven R. , Biankin, Andrew V.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: TPS4161-TPS4161

10.1200/jco.2014.32.15_suppl.tps4161 Get It

SWOG S0809: A phase II trial of adjuvant capecitabine (cap)/gemcitabine (gem) followed by concurrent capecitabine and radiotherapy in extrahepatic cholangiocarcinoma (EHCC) and gallbladder carcinoma (GBCA).
Ben‐Josef, Edgar , Guthrie, Katherine A. , Corless, Christopher L. , Zalupski, Mark M. , Lowy, Andrew M. , Thomas, Charles R., Micetich, Kenneth C., Thomas, Melanie B., Siegel, Abby B. , Blanke, Charles D. , El-Khoueiry, Anthony B. , Alberts, Steven R. , Dawson, Laura Ann

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 4030-4030

10.1200/jco.2014.32.15_suppl.4030 Get It

Aurora-A mitotic kinase and induction of endocrine resistance through downregulation of erα expression in initially erα+ breast cancer cells.
Salisbury, Jeffrey L., Zhang, Shuya , Hawse, John R. , Haddad, Tufia C. , D’Assoro, Antonino B. , Opyrchal, Mateusz , McCubrey, James Andrew , Goetz, Matthew P. , Degnim, Amy C. , Lange, Carol Ann , Ingle, James N. , Galanis, Evanthia

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 2568-2568

10.1200/jco.2014.32.15_suppl.2568 Get It

First results from the phase III ALTTO trial (BIG 2-06; NCCTG [Alliance] N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T→L), or their combination (T+L) in the adjuvant treatment of HER2-posi
Piccart, Martine , Holmes, Andrew , Baselga, José , Viale, Giuseppe , Zujewski, Jo Anne , Goldhirsch, Aron, Jackisch, Christian , Láng, István, Smith, Ian E., Boyle, Frances , Gelber, Richard D. , Perez, Edith A. , Azambuja, Evandro de , Dueck, Amylou C. , Zujewski, Jo Anne , Santillana, Sergio, Pritchard, Kathleen I. , Wolff, Antonio C. , Untch, Michael , Xu, Binghe , Gómez, Henry

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: LBA4-LBA4

10.1200/jco.2014.32.15_suppl.lba4 Get It

Alliance A091103: A multicenter phase II study of the angiopoietin-1 and -2 peptibody trebananib (AMG386) for the treatment of angiosarcoma (AS).
Mahoney, Michelle R., Tine, Brian Andrew Van, Adkins, Douglas, Perdekamp, Maria T. Grosse, Condy, Mercedes M., Hartley, Eliza W., Tap, William D. , D'Angelo, Sandra P , Adkins, Douglas, Antonescu, Cristina R. , Schwartz, Gary K.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 10568-10568

10.1200/jco.2014.32.15_suppl.10568 Get It